NPS has published independent
reviews of Januvia (sitagliptin) and
Galvus (vildagliptin) in the latest
edition of its Medicine Update
newsletter.
The articles outline who the
medicines are suitable for, how they
work and the ways in which they
differ from other medications for
type 2 diabetes, as well as possible
side effects and drug interactions.
Acting NPS ceo Karen Kaye said
anyone who is considering one of
the new medicines should read the
Medicine Update before having a
discussion with their doctor.
See nps.org.au/medicineupdate.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Aug 10
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.